GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ReproCELL Incorp (TSE:4978) » Definitions » Sale Of Investment

ReproCELLorp (TSE:4978) Sale Of Investment : 円0 Mil (TTM As of Dec. 2023)


View and export this data going back to 2013. Start your Free Trial

What is ReproCELLorp Sale Of Investment?

ReproCELLorp's sale of investment for the three months ended in Dec. 2023 was 円0 Mil. It means ReproCELLorp gained 円0 Mil from selling investments. ReproCELLorp's sale of investment for the trailing twelve months (TTM) ended in Dec. 2023 was 円0 Mil.

Compared with last quarter (円0 Mil in Sep. 2023 ), ReproCELLorp gained the same money from selling investments in Dec. 2023 (円0 Mil).


ReproCELLorp Sale Of Investment Historical Data

The historical data trend for ReproCELLorp's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ReproCELLorp Sale Of Investment Chart

ReproCELLorp Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Sale Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,870.53 654.79 2,014.00 2,143.00 4,602.30

ReproCELLorp Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Sale Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

ReproCELLorp Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ReproCELLorp Sale Of Investment Related Terms

Thank you for viewing the detailed overview of ReproCELLorp's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


ReproCELLorp (TSE:4978) Business Description

Traded in Other Exchanges
N/A
Address
KDX Shin-Yokohama 381 Bldg. 9F, 3-8-11, Shin-Yokohama, Kohoku-ku, Kanagawa, Yokohama, JPN, 222-0033
ReproCELL Incorp is one of the leading stem cell research company in Japan. The company provides stem cell services, predictive drug discovery services, tissue services, and molecular services.

ReproCELLorp (TSE:4978) Headlines

No Headlines